Ani Pharmaceuticals converts preferred stock to common shares, no preferred shares remain
PositiveFinancial Markets

Ani Pharmaceuticals has successfully converted all its preferred stock into common shares, marking a significant shift in its capital structure. This move not only eliminates the preferred shares but also strengthens the company's equity position, which could enhance investor confidence and attract new capital. Such changes are crucial for the company's growth and stability in the competitive pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System